[Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension]. 1976

J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
August 1973, Clinical science and molecular medicine. Supplement,
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
September 1971, Journal de medecine de Lyon,
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
December 1978, Clinical pharmacology and therapeutics,
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
July 1981, The Medical journal of Australia,
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
January 1977, La Prensa medica mexicana,
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
April 1975, Minerva medica,
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
March 1983, Medicina clinica,
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
April 1982, British journal of clinical pharmacology,
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
December 2019, Presse medicale (Paris, France : 1983),
J C de los Rios, and J Ortíz Feijoo, and F Otero Cagide
March 1962, The Tohoku journal of experimental medicine,
Copied contents to your clipboard!